Startups

Valinor Enterprises: $54 Million Series A Raised To Expand Defense-Tech Holding Company Model

By Amit Chowdhry ● Jan 9, 2026

Valinor Enterprises, an operational holding company focused on defense and government technology, said it raised $54 million in Series A financing, bringing total capital raised to more than $85 million. The round was led by Friends & Family Capital, a venture firm co-founded by former Palantir CFO Colin Anderson and investor John Fogelsong. Existing backers General Catalyst, Founders Fund, and Red Cell Partners also participated, while new investors included Narya, XYZ Venture Capital, and Fifth Down Capital.

AgileRL Raises Seed Round To Launch Arena RLOps Platform In The U.S.

By Amit Chowdhry ● Jan 8, 2026

AgileRL has raised a seed financing round backed by Fusion Fund and Flying Fish, with participation from existing investors Octopus Ventures and Counterview Capital, bringing the company’s total funding raised to $7.5 million.

Prudentia Sciences: $20 Million Series A Raised To Speed Life Sciences Deal Diligence

By Amit Chowdhry ● Jan 8, 2026

Prudentia Sciences announced it raised $20 million in Series A financing to expand its AI-native due diligence platform for life sciences dealmaking, aiming to help pharmaceutical companies, biotechs, and financial institutions evaluate therapeutic assets faster and with more rigor.

Luminate: $21 Million Series A Extension Closed To Scale At-Home Cancer Infusions And Patient-Led Delivery Technology

By Amit Chowdhry ● Jan 8, 2026

Luminate, a Galway, Ireland-based healthcare technology company focused on delivering cancer therapies in the home, has raised $21 million in an expanded Series A round, bringing total funding to more than $50 million. The round was co-led by ARTIS Ventures and Lachy Groom, with participation from Western Alliance Life Sciences and existing backers including 8VC, Y Combinator, Atlantic Bridge, Faber, SciFounders, and others. The company said the financing follows growing interest from health systems in its Lotus program for home-based cancer care.

Redgate Software Secures Growth Investment From Bregal Sagemount

By Amit Chowdhry ● Jan 8, 2026

Redgate Software announced it has received a strategic growth investment from Bregal Sagemount, a growth-focused private equity firm, in a transaction that will make Sagemount the majority shareholder of Redgate, pending regulatory approvals and customary closing conditions. Financial terms were not disclosed, and the companies said the deal is expected to close in late Q1 2026.

ATG Emerges From Stealth With $15 Million To Build An AI-Based Financial Advisor

By Amit Chowdhry ● Jan 8, 2026

Autonomous Technologies Group (ATG) announced it has emerged from stealth as an AI research lab focused on building an advanced AI financial advisor, positioning its flagship product, Autonomous, as a personalized investment strategist that combines market data, portfolio theory, behavioral finance, and user context to guide investment decisions.

Poplar Therapeutics Launched With $50 Million Series A To Advance Anti-IgE Therapy for Multiple Atopic Conditions

By Amit Chowdhry ● Jan 8, 2026

Poplar Therapeutics has launched as a clinical-stage immunology company with a $50 million Series A financing to advance PHB-050, a next-generation anti-IgE antibody being developed for food allergy and other atopic conditions such as asthma and atopic dermatitis.

IMVARIA Announces Strategic Investments For AI-Based Digital Biomarker Solutions

By Amit Chowdhry ● Jan 8, 2026

IMVARIA, a Berkeley, California-based health tech company developing AI-driven digital biomarker solutions, said it has secured strategic investments from new and existing investors to accelerate growth and expand its AI-powered diagnostic services.

Corsera Health: $80 Million Series A Raised To Advance Cardiovascular Disease Prediction

By Amit Chowdhry ● Jan 8, 2026

Corsera Health announced it raised an oversubscribed $80 million Series A to advance its cardiovascular disease prediction-and-prevention strategy and to fund development of once-annual preventive RNAi medicines targeting the two primary drivers of atherosclerotic cardiovascular disease (ASCVD): elevated LDL cholesterol and high blood pressure. The round was co-led by Forbion and Population Health Partners, with participation from additional investors including Corsera co-founder and co-CEO John Maraganore, Ph.D. As part of the financing, Forbion general partner Marco Boorsma, Ph.D., will join Corsera’s board.

Nocion Therapeutics: $93 Million Series B Closed To Advance Taplucainium Toward Late-Stage Development In Chronic Cough

By Amit Chowdhry ● Jan 8, 2026

Nocion Therapeutics announced it has raised $23 million from existing investors in an extension of its Series B financing, bringing the total Series B proceeds to $93 million as the company advances taplucainium, its investigational inhaled therapy for refractory or unexplained chronic cough.

Soley Therapeutics: $200 Million Series C Closed To Advance Oncology Assets Into the Clinic

By Amit Chowdhry ● Jan 8, 2026

Soley Therapeutics has raised $200 million in Series C funding to move its cell stress-sensing platform and pipeline into clinical development, including IND-enabling work and trials for two first-in-class, internally discovered oncology programs. The company said proceeds will also support the advancement of non-oncology stress-reducing drug candidates targeting neurodegenerative disorders and metabolic diseases, as well as continued platform scale-up.

Varsity Healthcare Partners Makes Growth Investment In Trialbee

By Amit Chowdhry ● Jan 8, 2026

Varsity Healthcare Partners (VHP), a lower middle-market healthcare services private equity firm, said it has completed a strategic growth investment in Trialbee, a Sweden-headquartered, technology-enabled provider of patient recruitment services and analytics for clinical trials.

Oasys: $4.6 Million Raised To Build An AI-Native Operating System For Behavioral Health

By Amit Chowdhry ● Jan 8, 2026

Oasys Health, which is known as an AI-native operating system for behavioral health, raised $4.6 million in funding to expand its platform that combines practice management, clinical decision support, and real-time physiological data from consumer wearables. The financing includes a $4 million seed round led by Pathlight Ventures with participation from Twine Ventures and Better Ventures, plus $600,000 in pre-seed funding from 1984 Ventures.

Lux: $1.5 Billion For Lux Ventures IX Closed

By Amit Chowdhry ● Jan 8, 2026

Lux, a venture capital firm focused on investing at the frontier of science and technology, announced the close of Lux Ventures IX, a $1.5 billion fund the firm described as its largest to date.

Spiro Medical: $67 Million Series Raised A To Develop Neuromodulation System For Asthma

By Amit Chowdhry ● Jan 8, 2026

Spiro Medical, a newly formed company focused on pulmonary neuromodulation for asthma, has closed a $67 million Series A equity financing to develop what it describes as a first-of-its-kind Pulmonary Neuromodulation System (PNM) for the treatment of asthma.

STRM.BIO: $8 Million Series Seed 2 Closed To Advance Non-Viral Gene Delivery For In Vivo Cell Engineering And Gene Therapy

By Amit Chowdhry ● Jan 8, 2026

STRM.BIO raised $8 million in a Series Seed 2 financing to advance its non-viral gene delivery platform for in vivo cell engineering and gene therapy. The round included funding from Recordati, with continued participation from Boehringer Ingelheim Venture Fund and Delos Capital, plus new backing from Blue Bay Capital Fund; the Seed 2 round remains open with plans to close by Q1 2026.

Swap: $100 Million Series C Raised To Expand Global Commerce Platform

By Amit Chowdhry ● Jan 8, 2026

Swap has raised a $100 million Series C round co-led by DST Global and ICONIQ, with ICONIQ increasing its stake after leading the company’s $40 million Series B six months earlier. The New York-based startup positions itself as a “commerce operating system,” evolving from a returns-focused product into a broader platform spanning cross-border commerce, tax, and demand planning.

Luxury Presence: $37 Million Secured To Launch Presence CRM

By Amit Chowdhry ● Jan 8, 2026

Luxury Presence said it has raised $37 million in new financing to accelerate the rollout of Presence CRM, a product the company describes as the first “AI relationship engine” designed to help real estate agents identify deal opportunities already embedded in their networks.

Cyera: $400 Million Series F At $9 Billion Valuation Raised As Enterprises Ramp Up AI Security

By Amit Chowdhry ● Jan 8, 2026

Cyera, an AI and data security company, has raised $400 million in a Series F funding round led by funds managed by Blackstone, pushing the company’s valuation to $9 billion and bringing total funding to more than $1.7 billion. The financing comes roughly six months after Cyera’s prior round and marks a valuation that the company says has tripled over the past year.

ViCentra Expands Series D To $98 Million To Scale Kaleido Insulin Patch Pump Commercialization

By Amit Chowdhry ● Jan 8, 2026

ViCentra, a European medical device company commercializing the Kaleido insulin patch pump system, said it has added $13 million in new capital to its Series D financing, bringing the total round to $98 million. The second close includes new investments from ROM Utrecht Region and a consortium of Dutch investors, including Venturing Tech, as well as increased backing from existing investor Innovation Industries.

Sibros Raises $9 Million in Growth Financing

By Amit Chowdhry ● Jan 8, 2026

Sibros has raised $9 million in a growth financing round, with Niterra Co., Ltd. participating in the investment as the software-defined vehicle (SDV) platform provider looks to expand product capabilities and scale commercialization.

TECregen Raises CHF 10 Million Seed Round, Names Dr. Bo Rode Hansen Chairman

By Amit Chowdhry ● Jan 8, 2026

Basel, Switzerland-based TECregen has raised CHF 10 million (approximately €10.7 million / $12.6 million) in seed financing to advance a new class of thymus-rejuvenating biologics aimed at restoring immune function by rejuvenating thymic epithelial cells (TECs). The round was led by the Boehringer Ingelheim Venture Fund (BIVF) and included participation from LifeSpan Vision Ventures, Carma Fund, EOS BioInnovation, High-Tech Gründerfonds (HTGF), the JFG Life Sciences Foundation of the University of Basel, and Zurich Cantonal Bank.

Enable Injections Announces $30 Million Sanofi Investment To Expand enFuse On-Body Injector Manufacturing

By Amit Chowdhry ● Jan 8, 2026

Enable Injections announced that Sanofi is making a $30 million investment in the Cincinnati-based drug delivery company to accelerate a manufacturing build-out, bolster supply chain capabilities, and support commercial growth for its enFuse on-body delivery system.

Protege: $30 Million Raised To Expand Real-World Data Access For AI Development

By Amit Chowdhry ● Jan 8, 2026

Protege, an AI data platform focused on unlocking trusted, real-world datasets at scale, has raised a $30 million Series A round led by Andreessen Horowitz (a16z). The financing expands the company’s previously announced $25 million Series A from August 2025 and brings total funding to $65 million since Protege’s founding in 2024. Returning investors include Footwork, CRV, Bloomberg Beta, Flex Capital, Shaper Capital, and others.

Parabilis Medicines: $305 Million Series F Raised To Advance Zolucatetide Program And Helicon Peptide Platform

By Amit Chowdhry ● Jan 8, 2026

Parabilis Medicines, a clinical-stage cancer drug developer, said it has closed an oversubscribed $305 million Series F financing to fund ongoing clinical development of its lead candidate FOG-001 (zolucatetide) across multiple tumor types and to expand a broader pipeline built on its Helicon peptide platform. The round was co-led by RA Capital Management, Fidelity Management & Research Company, and Janus Henderson Investors. Parabilis said new investors in the financing included Frazier Life Sciences, Soleus Capital, and a life science-dedicated investment fund, alongside participation from a broad syndicate of existing backers including venBio Partners, Cormorant Asset Management, ARCH Venture Partners, GV, accounts advised by T. Rowe Price Associates, Marshall Wace, General Catalyst, Invus, Farallon Capital Management, Foresite Capital, Rock Springs Capital, HBM Healthcare, Samsara BioCapital, Catalio Capital Management, and others.

NovaWave Capital Adds New Investors And Unveils Arizona “WaveX” AI Venture Studio With State Commerce Authority

By Amit Chowdhry ● Jan 8, 2026

NovaWave Capital announced it has reached a new milestone for its NovaWave Fund I generation, adding AZ Venture Capital Inc. and Sunny Day Sports as incoming investors, as it expands its public-private capital base to support innovation across the U.S.

Babylon Raises $15 Million From a16z Crypto To Enable Native Bitcoin Collateral

By Amit Chowdhry ● Jan 7, 2026

Babylon announced that it has raised $15 million from a16z crypto to develop Babylon Trustless BTCVaults, an infrastructure system designed to let native Bitcoin be used as collateral across on-chain financial applications without relying on wrapping, custodians, or intermediaries.

Rakuten Medical: $100 Million Series F Raised To Accelerate U.S. Path For ASP-1929

By Amit Chowdhry ● Jan 7, 2026

Rakuten Medical, a San Diego-based biotechnology company developing its Alluminox platform-based photoimmunotherapy, has closed a $100 million oversubscribed Series F financing to support a global Phase 3 program for its lead investigational therapy ASP-1929 and advance toward a planned U.S. Biologics License Application submission in 2028.

Mediar Therapeutics: $76 Million Series B Raised As Fibrosis Programs Advance

By Amit Chowdhry ● Jan 7, 2026

Mediar Therapeutics, a clinical-stage biotech developing first-in-class therapies designed to halt fibrosis, said it closed an oversubscribed $76 million Series B financing co-led by Amplitude Ventures and ICG as it advances a portfolio of antibody programs targeting fibrotic diseases affecting the skin, lung, and kidney.

Sigrid: $5 Million Raised To Scale Non-Systemic Metabolic Health Platform

By Amit Chowdhry ● Jan 7, 2026

Sigrid, a Swedish consumer health company focused on metabolic health through non-systemic science, announced it has raised $5 million to accelerate commercialization and platform expansion, bringing its total capital raised to about $27 million.